Navigation Links
Cowen Group, Inc. Announces 2008 First Quarter Results
Date:5/8/2008

ransaction volume due to an overall decrease in public

capital raising activity, both market-wide and in Cowen's target

sectors. In the first quarter of 2008, the company co-managed 4

offerings of equity securities for 4 companies, raising proceeds of

$19.8 billion ($0.2 billion excluding Visa proceeds of $19.6 billion).

In the first quarter of 2007, the company lead-managed 3 offerings and

co-managed 9 offerings of equity and convertible securities for 11

companies raising proceeds of $2.0 billion.

-- Private equity revenue was $1.3 million in the first quarter of 2008,

a decrease of $2.8 million, or 69% compared to $4.1 million in the

first quarter of 2007. The decrease was primarily attributable to

decreased transaction volume consistent with the overall slowdown in

private capital raising activity. During the first quarter of 2008,

the company completed 1 private transaction raising proceeds of

approximately $55 million. In the first quarter of 2007, the Company

completed 3 private transactions raising proceeds of approximately

$87 million.

-- Strategic advisory revenue was $11.1 million in the first quarter of

2008, an increase of $3.1 million, or 39%, compared to $8.0 million in

the first quarter of 2007. The year-over-year increase was the result

of increased transaction volume. Volume across Cowen's sectors

increased modestly while activity across the broader market decreased.

During the first quarter of 2008, Cowen completed 6 strategic advisory

assignments with an aggregate value of $1.2 billion. In the first

quarter of 2007, the Company completed 3 strategic advisory

assignments with an aggregate value of $0.7 billion.

As of March 31, 2008, Cowen had 13 filed transactions in its public equity backlog,
'/>"/>

SOURCE Cowen Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. ISTA Pharmaceuticals Engages Cowen as Financial Advisor
2. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
3. Transdel Pharmaceuticals to Present at Cowen and Companys 28th Annual Health Care Conference
4. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
5. MannKind to Present at the Cowen and Company Healthcare Conference
6. Johnson & Johnson to Participate in the 28th Annual Cowen & Company Health Care Conference
7. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference
8. ISTA Pharmaceuticals to Present at the Cowen & Company 28th Annual Health Care Conference
9. XTENT to Present at Cowen and Companys 28th Annual Health Care Conference
10. Iomai CEO to Speak at Cowen and Company Health Care Conference on Monday, March 17
11. Edwards Lifesciences to Present at the Cowen and Company Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... were treated with cisplatin-based chemotherapy ha... side effects and Raynaud-like phenomena, than men... to a new study published online November 25 in th...Marianne Brydy, M.D., of the Department of Oncolog...y, and colleagues conducted a cross-sectional stud...
(Date:11/25/2009)...thritis, could help newly diagnosed diabetics, stu...ay News) -- A drug commonly used to treat non-Hodg...hows some promise in helping patients newly diagno... (Rituxan), helped patients keep producing some of...stroyed some of their pancreatic beta cells, which...
(Date:11/25/2009)...incare ®isproudtosupportGNC,seffortstoraisemo...de ThanksandGiving campaign,$1fromthepurchaseprice... willbedonatedtoSt.Jude.Additionally,GNCcustomersh...utatoneoftheir5,000+retaillocationsoratGNC.com.GNC...2009 ThanksandGiving campaign. ,, "Wearedelight...
(Date:11/25/2009)... in children with autism and related conditions ca...edication combined with a structured training prog...archers and their colleagues. , Published in th...can Academy of Child and Adolescent Psychiatry , t...f Mental Health (NIMH) Research Units on Pediatric...
(Date:11/25/2009)...emier resource for life science careers and inform...™ Hotbed Campaign this morning. , ...2009 -- BioSpace.com, the premier resource for lif...ird edition of the BioForest™ Hotbed Campaig... a promotional effort highlighting biotechnology, ...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
...ew, expanded broad-spectrum IV antibiotic that can...ctions including those caused by antibiotic// resi...ylococcus aureus (MRSA). It will be available in t...re running out of options. "Difficult to tre...
...due to anthrax being confirmed from Koothattukulam...taken preventive measures to contain the spread of...es collected from of the carcasses of one the cows...re conducted at the Avian Diseases Diagnostic Regi...
...al cord injury who experience recurring problems ...ssive therapy to avoid further cardiovascular// pr... Medical College of Georgia. A study subset ...ient, says Dr. Andres F. Ruiz-Arango, cardiology f...
...lantic University, the Center for Breast Care at t..., and MeVis, The Center for Diagnostic// Systems a...any have developed new techniques to aid clinician...imaging techniques for the analysis and display of...
...s, the labs of Yale Goldman, MD, PhD, Director of ...y of Pennsylvania School of Medicine,// and Erika ...shed a group of papers that, taken together, show ...ead to better ways to treat motor neuron diseases....
... in Australia to help men manage with breast cance...so that men who are diagnosed// every year have th...er Center (NBCC) maintains the website. It w...d that the new website will provide specific infor...
Other Medicine News:Health News:Broad Spectrum Antibiotic Available for Antibiotic Resistant Bacteria 2Health News:Aggresive Therapy Needed for Cervical Spinal Cord Injuries 2Health News:Aggresive Therapy Needed for Cervical Spinal Cord Injuries 3Health News:New Tool to Diagnose and Treat Breast Cancer 2Health News:New Tool to Diagnose and Treat Breast Cancer 3Health News:Discovery of Agile Molecular Motors Could Aid in Treating Motor Neuron Diseases 2
(Date:11/25/2009)...ire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedi...mallydisruptivesurgicaltreatmentsforthespine,annou...ember30,2009,at5:30p.m.ET/2:30p.m.PT.Theconference...tfortheCompany,sproductsandwillincludecommentsfrom....Thedial-innumbersare1-877-407-4018fordomesticcall...
(Date:11/25/2009)...JOHANNESBURG,November25/PRNewswire/--,iThembaPharm...edtoday,thattheyhavesignedacollaborativeagreementt...s,sworldclasscomputationalchemistryandleaddiscover...ontoprovidemedicinaland,syntheticchemistrysupportt...ntnetwork.iThembaPharmaceuticalsandPyxisDiscovery,...
(Date:11/24/2009)...swire/-- ,, WHAT:RomHoubens,aBelgianmanthoughtt...asactuallyfullyconsciousandawakeduringthattimeandw...xEyeMaxwasfeaturedinthesegmenttoillustratehowpeopl...ommunication. ,, WHEN:GoodMorningAmerica-- Tues...h.com ,, WHO:RomHoubenswasanengineeringstud...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2GenVaults GenSolve 28TM 29 Reagents Enable State of the Art Genomic Analysis of Dried Blood Spots 53720 1GenVaults GenSolve 28TM 29 Reagents Enable State of the Art Genomic Analysis of Dried Blood Spots 53720 2GenVaults GenSolve 28TM 29 Reagents Enable State of the Art Genomic Analysis of Dried Blood Spots 53720 3Article Now Available 3A Are Special Orders Draining Your Budgets 3F 53715 1Article Now Available 3A Are Special Orders Draining Your Budgets 3F 53715 2Article Now Available 3A Are Special Orders Draining Your Budgets 3F 53715 3Ceregene Receives Additional Grant From Michael J Fox Foundation to Expand Long Term Testing of CERE 120 Patients 13382 1Ceregene Receives Additional Grant From Michael J Fox Foundation to Expand Long Term Testing of CERE 120 Patients 13382 2Ceregene Receives Additional Grant From Michael J Fox Foundation to Expand Long Term Testing of CERE 120 Patients 13382 3Ceregene Receives Additional Grant From Michael J Fox Foundation to Expand Long Term Testing of CERE 120 Patients 13382 4
...ONDON, Oct. 23 Morria Biopharmaceuticals Plc, a,b...t of novel,anti-inflammatory drugs, today announce...RX-4 in 16 patients suffering from allergic rhinit...le blind clinical trial is the,first of two module...y in,AR. MRX-4 is nasally administered as a single...
...ASHINGTON, Oct. 22 Today, the American,Society of...ical Oncology,(ASCO) have released an updated join...ng agents (ESAs), a class of drugs that stimulate,...o treat,chemotherapy-related anemia., "One goal o...e most,up-to-date evidence from high-quality studi...
Other Medicine Technology:Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis 2ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 2ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 3
Medic 6 Defibrillator
Ring with Knob Folding Silicone Pessary
Hodge Silicone Folding Pessary Manually Shapeable
Incontinence Ring Silicone Flexible Pessary
Medicine Products: